Srivanichakorn 2015.
Methods | 8‐week randomised controlled trial |
Participants | Participants with type 2 diabetes who had been treated with insulin for at least 3 years plus moderate to high doses of sulphonylureas |
Interventions | Withdrawal of sulphonylureas (insulin monotherapy) (n = 16) or continuation (n = 16) of sulphonylureas |
Outcomes | HbA1c, insulin secretion |
Notes | Need to determine whether participants were adequately controlled |